Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children
- PMID: 22136960
- DOI: 10.1016/j.arcmed.2011.06.010
Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children
Abstract
Background and aims: Supplementation with n3 long-chain polyunsaturated fatty acids (n3-LCPUFA) appears to affect body weight, adipokines, and insulin resistance (IR) in obese individuals. However, it is unclear whether the effect on IR is independent of weight loss and if the same effect is observed in children. We undertook this study to analyze the effect of supplementation with n3-LCPUFA on adipokine concentration and IR of prepubertal and pubertal children, independent of weight loss.
Methods: Included were 76 children, 9- to 18-years of age. Subjects were overweight and insulin resistant, but otherwise healthy. They were randomly assigned to receive 900 mg n3-LCPUFA daily (Omega III, Salmon Oil, GNLD) or placebo for 1 month. No dietary intervention was conducted. Dietary information, anthropometry, and blood samples to measure adipokines and IR were obtained at baseline. Anthropometry and measurement of biochemical parameters were repeated at the end of follow-up. For analysis, children were stratified by treatment (placebo and n3-FA) and according to changes in body weight (increase, decrease, unchanged).
Results: Twenty seven children received placebo and 49 received the n3-LCPUFA. Despite no differences at baseline, only the n3-FA group decreased fasting insulin and HOMA-IR (p <0.010). Significant differences between groups were observed for changes in TNF-α, leptin and adiponectin after supplementation (p <0.050). At the end of the 1-month period, 16 children lost weight and 27 children gained weight. Multiple analysis demonstrated that supplementation with n3-LCPUFA decreased HOMA-IR by 15% after adjusting for puberty, treatment adherence, changes in adipokines, and weight loss. Interaction between supplementation and weight loss was significant (p = 0.007).
Conclusions: Supplementation with n3-LCPUFA is a potential beneficial tool for obese at-risk children.
Copyright © 2011 IMSS. Published by Elsevier Inc. All rights reserved.
Similar articles
-
A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss.Int J Obes (Lond). 2010 May;34(5):852-8. doi: 10.1038/ijo.2009.282. Epub 2010 Jan 12. Int J Obes (Lond). 2010. PMID: 20065970
-
Ghrelin levels before and after reduction of overweight due to a low-fat high-carbohydrate diet in obese children and adolescents.Int J Obes (Lond). 2005 Apr;29(4):362-8. doi: 10.1038/sj.ijo.0802913. Int J Obes (Lond). 2005. PMID: 15768041
-
Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity.Clin Endocrinol (Oxf). 2006 Feb;64(2):169-78. doi: 10.1111/j.1365-2265.2006.02444.x. Clin Endocrinol (Oxf). 2006. PMID: 16430716
-
Supplementation of N-3 LCPUFA to the diet of children older than 2 years: a commentary by the ESPGHAN Committee on Nutrition.J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):2-10. doi: 10.1097/MPG.0b013e318216f009. J Pediatr Gastroenterol Nutr. 2011. PMID: 21694531 Review.
-
The effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on obesity measures in the offspring: an up-to-date systematic review and meta-analysis.Eur J Nutr. 2019 Oct;58(7):2597-2613. doi: 10.1007/s00394-018-1824-9. Epub 2018 Sep 24. Eur J Nutr. 2019. PMID: 30251019 Free PMC article.
Cited by
-
A randomized control trial of the impact of LCPUFA-ω3 supplementation on body weight and insulin resistance in pubertal children with obesity.Pediatr Obes. 2019 May;14(5):e12499. doi: 10.1111/ijpo.12499. Epub 2018 Dec 27. Pediatr Obes. 2019. PMID: 30590877 Free PMC article. Clinical Trial.
-
[The Medical Nutrition Research Unit: towards the new challenges of translational research].Rev Med Inst Mex Seguro Soc. 2025 Jan 2;63(Suppl 1):e6345. doi: 10.5281/zenodo.10814249. Rev Med Inst Mex Seguro Soc. 2025. PMID: 40489666 Free PMC article. Spanish.
-
Obesity Prevention for Children with Developmental Disabilities.Curr Obes Rep. 2014 Jun;3(2):156-70. doi: 10.1007/s13679-014-0098-7. Curr Obes Rep. 2014. PMID: 25530916 Free PMC article.
-
Does Fish Oil Have an Anti-Obesity Effect in Overweight/Obese Adults? A Meta-Analysis of Randomized Controlled Trials.PLoS One. 2015 Nov 16;10(11):e0142652. doi: 10.1371/journal.pone.0142652. eCollection 2015. PLoS One. 2015. PMID: 26571503 Free PMC article.
-
Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome.Int J Mol Sci. 2019 Apr 29;20(9):2118. doi: 10.3390/ijms20092118. Int J Mol Sci. 2019. PMID: 31035722 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical